Development and validation of a mass spectrometry solution for core laboratories begins at Australian hospital

An Australian hospital project aims to streamline clinical testing through automated sample preparation and connected laboratory informatics

4 Nov 2026
CLAM-2040 CL Fully Automated Sample Preparation Module and LCMS-8060 CL Triple Quadrupole Mass Spectrometer

CLAM-2040 CL Fully Automated Sample Preparation Module and LCMS-8060 CL Triple Quadrupole Mass Spectrometer

Summary: Shimadzu Corporation is developing and validating an automated liquid chromatography–mass spectrometry (LC-MS) solution at St. Vincent’s Hospital in Melbourne, Australia. Integrating Shimadzu’s sample preparation and mass spectrometry systems with Abbott’s AlinIQ AMS laboratory informatics solution, the project aims to streamline core laboratory workflows and support faster, more reliable diagnostic testing.


Shimadzu Corporation has started the development and validation of a mass spectrometry solution for core laboratories at St. Vincent’s Hospital in Melbourne, Victoria, Australia. Shimadzu’s LC-MS-based automation solution has been integrated with Abbott Laboratories’ AlinIQ AMS laboratory informatics solution to streamline and automate clinical testing workflows in core laboratories. The solution is being developed and validated with the aim of supporting faster and more reliable diagnostic testing in healthcare settings.

Mass spectrometry using LC-MS is an analytical technique that directly measures compounds in biological samples such as blood at the molecular level, enabling highly accurate identification and quantification of target substances. Compared with conventional immunoassays, it offers superior analytical performance, reliability, and is widely used in applications such as therapeutic drug monitoring, infectious disease testing, and newborn screening.

While demand for advanced clinical testing continues to grow, driven by the increasing sophistication of healthcare, laboratories face challenges in securing personnel with specialized analytical expertise. As a result, the need for faster testing, workflow automation, and seamless data connectivity is becoming increasingly important.

Shimadzu’s automation solution, comprising the CLAM-2040 CL fully automated sample preparation module, the LCMS-8060 CL triple quadrupole mass spectrometer, and reagent kits, connected to Abbott’s AlinIQ AMS laboratory informatics solution, establishes a seamless mass spectrometry solution.

In the Mid-Term Management Plan announced on June 4, 2026, Shimadzu identified its clinical business, centered on molecular diagnostics, as one of its core growth drivers. Going forward, Shimadzu will continue to collaborate with global partners to advance the development and validation of clinical testing solutions, enhance customer value, and expand its business in the global healthcare market.

Want to learn more? Hear directly from the experts at St. Vincent’s Hospital in Melbourne in this exclusive webinar

Shimadzu webinar CLAM 2040 Amanda Bergamin St Vincents Pathology, Melbourne

CLAM-2040

Shimadzu Corporation

The CLAM-2040 accompanies you on most of the analytical workflow and improves your overall throughput by drastically reducing the sample preparation time.

(0)

Links

Related content

Tags

Clinical ChemistryBiochemistry (or clinical chemistry) involves the analysis of bodily fluids using chemical tests. Techniques used include HPLC, chromatography, spectroscopy, mass spectrometry, immunochemical, electrophoresis, turbidometric / spectrophotometric assay, MRI and ISE analysis. Tests are often carried out on plasma or serum but urine (urinalysis) and fecal specimens are also processed.LC-MSLC-MS (liquid chromatography-mass spectrometry) systems and equipment are used for separation and quantitative analysis of complex mixtures, combining liquid chromatography and mass spectrometry. Quantify proteins, contaminants, pesticides or screen for drug metabolites with a high level of sensitivity. LC-MS systems and equipment include reverse phase, normal phase and specialized columns integrated with various MS detectors such as time-of-flight (TOF), quadrupole, orbitrap or ion trap mass analyzers. LC-MS/MS instruments equipped with a qTOF or triple quadrupole analyzer give greater sensitivity and resolving power to your analysis. Find the best LC-MS equipment in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Clinical Mass SpectrometryMass spectrometry is emerging as a superior method of analysis over the longstanding, gold standard of immunoassay. Clinical mass spectrometry systems are increasingly accessible to medical laboratories and are capable of providing results with more speed and less expense than traditional methods. From simple mass spectrometers to IVDR class A compliant, highly sophisticated systems performing liquid chromatography tandem mass spectrometry (LC/MS/MS), find the latest product news, reviews and resources to make a purchasing decision for your laboratory.

Frequently asked questions

Show frequently asked questions

What is Shimadzu developing for core laboratories?

Shimadzu is developing and validating an automated LC-MS solution that integrates sample preparation, mass spectrometry and laboratory informatics to streamline clinical testing workflows in core laboratories.

Where is Shimadzu’s LC-MS solution being developed and validated?

Development and validation are taking place at St. Vincent’s Hospital in Melbourne, Victoria, Australia.

Which systems are included in the automated LC-MS solution?

The solution comprises Shimadzu’s CLAM-2040 CL fully automated sample preparation module, LCMS-8060 CL triple quadrupole mass spectrometer and reagent kits, connected to Abbott’s AlinIQ AMS laboratory informatics solution.

What is LC-MS used for in clinical testing?

Liquid chromatography–mass spectrometry measures compounds in biological samples, such as blood, to identify and quantify target substances. Clinical applications described in the article include therapeutic drug monitoring, infectious disease testing and newborn screening.

How could LC-MS automation support core laboratory workflows?

The project aims to streamline testing through automated sample preparation and connected laboratory informatics. It is being developed and validated to support faster, more reliable diagnostic testing as laboratories face growing demand and challenges in securing specialist analytical expertise.